JAZZ News and Press, Jazz Pharmaceuticals plc From 04/11/21

When GW Pharmaceuticals ' (NASDAQ: GWPH) cannabidiol-based drug, Epidiolex, came onto the pharmaceutical scene, cannabis investors rejoiced. Jazz Pharmaceuticals (NASDAQ: JAZZ) recently announced plans to acquire GW Pharma, and to bring its seizure treatment into a larger po...

Why aren't US cannabis stocks reflecting more fundamental bullish developments? CNBC's Tim Seymour joins us to discuss this and his actively managed ETF, CNBS. Top line revenue will be very robust this year. SAFE Banking and waiting to hear what happens in Texas. Cannabis coverage...

Cannabis research -- even for medical purposes -- is highly restricted in the United States. But we have seen plenty of glimmers of hope about its benefits, and signals that cannabis can treat severe disease. Take, for instance, Jazz Pharmaceuticals' (NASDAQ: JAZZ) recent announceme...

PRINCETON, N.J., April 05, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced t...

The biotechnology industry is expected to expand significantly over the next few years on the back of favorable government initiatives and the emergence of innovative players. Amgen (AMGN), Gilead Sciences (GILD), Qiagen (QGEN), and Jazz (JAZZ) already possess strong portfolios of products an...

Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients PR Newswire DUBLIN , March 30, 2021 /PRNewswire/ -- Jazz Pharmaceu...

According to the federal database of drugs, the FDA has approved a supplemental New Drug Application (sNDA) for Vyxeos (daunorubicin and cytarabine) liposome for injection developed by Jazz Pharmaceuticals ([[JAZZ]] -0.5%).Per the new label, Vyxeos is indicated for therapy-related acute ...

Merger activity increased last week. The bidding war for Coherent comes to an end. The acquisition of MSG Networks (MSGN) by Madison Square Garden Entertainment. For further details see: Merger Arbitrage Mondays - Multiple Deals In Bidding Wars

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The energy and shipping markets take center stage next week as the drama in the Suez Canal continues to play out and OPE...

There has been a surge of mergers and acquisitions activity in the cannabis industry of late. Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) are linking up in one of the sector's highest-profile mergers, and other industries are getting in on the action. Jazz Pharmaceutic...